RNAO has led the way in advocating for mandatory COVID-19 vaccination for health-care workers in Ontario. There is strong and growing evidence about the effectiveness of the COVID-19 vaccines in preventing serious illness and hospitalization, as well as in reducing transmission of the virus.
The Registered Nurses’ Association of Ontario (RNAO) has launched a new #FullyVaccinated social media campaign to encourage everyone to receive both doses of the COVID-19 vaccine, and is calling for mandatory vaccination for health-care workers in contact with patients.
RNAO has lead the advocacy for mandatory COVID-19 vaccination for healthcare workers in Ontario. Drawing on experts, in this article we explore the issues and challenges involved and the way forward.
This month, RNAO spoke out on a number of prominent issues in the media including COVID-19 vaccinations, the province’s reopening framework, the ineffectiveness of signing bonuses for new staff, the urgency to repeal Bill 124, and the welcoming of Ontario’s new Chief Medical Officer of Health Dr. Kieran Moore.
This week we consider the shocking status of vaccine inequity from a global perspective. World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said recently that the world is at risk of 'vaccine apartheid'. The WHO chief highlighted that at least 63 million doses of vaccines have been shipped to 124 countries and economies, but they represent just 0.5 per cent of the combined population of those nations. He also noted that the basic problem of vaccine inequity was a lack of sharing by the wealthy countries that have accumulated most of the vaccine supplies.
This article addresses the shocking contrast between Canada's declarations of concern with the global distribution of vaccines, and the poor reality of its actions. Joel Lexchin, Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto tackles this question.
As we reach enormously successful levels of COVID-19 inoculation in Canada and other rich countries, the disparities with the rest of the world become starker. This article considers the enormous cost in lives of leaving most of the global population unvaccinated. It draws lessons on how we can do better from the effort to provide lifesaving drugs for HIV-AIDS in the 1990s. This June 22 article is by Maria De Jesus, Associate Professor and Research Fellow at the Center on Health, Risk, and Society, American University School of International Service.
One question not addressed in the article above by Dr. Alexander Wong is the dosing interval between the first AstraZeneca (AZ) vaccine, and the second dose (whether AZ or mRNA). This is a topical question, which I address in the commentary that follows.
Ontarians have received about 900,000 doses of the AstraZeneca vaccine, mostly as a first dose. These Ontarians now have the choice of getting a second dose of the AstraZeneca or an mRNA vaccine. The following article, addressing the question of which one they should choose, is from Alexander Wong, an associate professor of infectious diseases at the University of Saskatchewan.